Marathon Pharmaceuticals – Focusing on Drugs for Those Having Rare Diseases

With offices in Illinois, Northbrook, New Jersey, and Chicago, the mission of Marathon Pharmaceuticals is working with patients with unmet medical needs or rare diseases. While many pharmaceutical companies are focusing on large-scale treatments and medicines for diseases that are easy to manufacture, MarathonPharmaceuticals is specializing in small-volume and difficult-to-manufacture solutions for patients. Patients with rare diseases usually have few treatment options. Marathon Pharmaceuticals recognizes the needs of these patients.


Recently, the company made an announcement about the Marathon Bioscience Center opening, which will be serving as a channel for the development of the latest therapies for movement disorders, gastrointestinal diseases, endocrine deficiencies, central nervous system diseases, and cancer.


The staff at Marathon Pharmaceuticals’ new Bioscience Center is highly experienced and composed of research, regulatory, and clinical professionals. This Bioscience Center puts the company’s new operations near MATTER, which is a hub for healthcare and biotechnology startups. Merchandise Mart, MATTER is located in Chicago, and it’s home to more than 200 startups working with hospitals and healthcare professionals to fight with complex medical problems.


ZiNGO Launch


Marathon’s most popular product launch is ZiNGO (lidocaine hydrochloride monohydrate), a powder intradermal injection system. It’s a needle-free and easy-to-use device used in delivering local anaesthetic for the purpose of managing venous access pain. ZiNGO is geared towards kids ages 3 to 18, experiencing the worst anxiety at the time of needle insertions.


This hand-held, single-use device does not need refrigeration. Just with the push of one button, the product delivers a dosage of 0.5 mg of powdered lidocaine (Xylocaine) to the application area. The lidocaine particles are then transferred through your skin through the use of a helium-powered delivery system.


The product numbs the application area within 1-3 minutes, thus medical providers can use ZiNGO during procedures without having to interrupt care. Also, there is no need of worrying about the effects lasting for a long period because the lidocaine powder will diminish after ten minutes.


To market and distribute this product, Marathon partnered with Medline, which is a global distributor of clinical solutions and medical supplies. The collaboration brought together the best healthcare professionals in the industry focused on patient care.